Pricing Log in Create free account

BioVie Inc. (BIVI) vs BioLineRx Ltd. (BLRX)

BioVie Inc. and BioLineRx Ltd. are both Biotechnology companies. BioVie Inc. and BioLineRx Ltd. are of similar size ($10.2M and $9.6M). BioVie Inc. has the higher net margin (0.00% vs −502.1%) and the lower return on invested capital (−1,095.0% vs −74.3%). Across the 14 metrics below, BioLineRx Ltd. leads on 8 and BioVie Inc. on 6.

Valuation

Metric BIVI BLRX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 6.51 9.71
P/B 0.85 0.55 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 1.93 9.21
Earnings yield (262.50%) (82.84%) (33.15%)
Free cash flow yield (218.80%) (119.61%) (25.50%)

Profitability

Metric BIVI BLRX Biotechnology median
Gross margin 0.00% 80.03% 65.16%
Operating margin 0.00% (874.28%) 0.00%
Net margin 0.00% (502.08%) 0.00%
Free cash flow margin 0.00% (776.29%) 0.00%
Return on equity (151.06%) (38.10%) (56.36%)
Return on assets (123.51%) (18.21%) (48.04%)
Return on invested capital (1,095.01%) (74.28%) 0.00%

Growth

Metric BIVI BLRX Biotechnology median
Revenue growth (TTM) — (91.93%) 6.02%
EPS growth (last fiscal year) 74.83% 93.72% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIVI BLRX Biotechnology median
Debt to equity 0.00 0.40 0.00
Current ratio 3.59 1.20 4.72
Net debt to EBITDA 0.40 1.22 0.96

Dividend

Metric BIVI BLRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BIVI BLRX Biotechnology median
Market cap 9.64m 10.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack